Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1988 Jan;93(1):69–78. doi: 10.1111/j.1476-5381.1988.tb11406.x

Zolantidine (SK&F 95282) is a potent selective brain-penetrating histamine H2-receptor antagonist.

C R Calcutt 1, C R Ganellin 1, R Griffiths 1, B K Leigh 1, J P Maguire 1, R C Mitchell 1, M E Mylek 1, M E Parsons 1, I R Smith 1, R C Young 1
PMCID: PMC1853786  PMID: 2894879

Abstract

1. The novel benzthiazole derivative zolantidine (SK&F 95282) is a potent antagonist of histamine at H2-receptors in guinea-pig atrium and rat uterus. Only apparent pA2 values of 7.46 and 7.26 respectively could be calculated since the slopes of the Schild plots were significantly less than unity. 2. Zolantidine is equally potent as an antagonist at histamine H2-receptors in guinea-pig brain. The compound inhibited histamine stimulated adenylate cyclase (pKi 7.3) and dimaprit stimulated adenosine 3':5'-cyclic monophosphate (cyclic AMP) accumulation (approx pA2 7.63), and competed with [3H]-tiotidine binding (pKi 7.17). 3. Zolantidine is at least 30 fold more potent at H2-receptors than at other peripheral and central receptors investigated. 4. Infusion of zolantidine into rats produces a brain concentration greater than the plateau blood concentration (brain/blood ratio 1.45). 5. Zolantidine is thus characterized as a potent selective brain-penetrating H2-receptor antagonist, and will be a valuable pharmacological tool for investigating possible physiological and pathological roles for histamine in the central nervous system.

Full text

PDF
69

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arrang J. M., Garbarg M., Schwartz J. C. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature. 1983 Apr 28;302(5911):832–837. doi: 10.1038/302832a0. [DOI] [PubMed] [Google Scholar]
  3. Barbin G., Palacios J. M., Garbarg M., Schwartz J. C., Gaspar P., Javoy-Agid F., Agid Y. L-Histidine decarboxylase in the human brain: properties and localization. J Neurochem. 1980 Aug;35(2):400–406. doi: 10.1111/j.1471-4159.1980.tb06278.x. [DOI] [PubMed] [Google Scholar]
  4. Black J. W., Duncan W. A., Durant C. J., Ganellin C. R., Parsons E. M. Definition and antagonism of histamine H 2 -receptors. Nature. 1972 Apr 21;236(5347):385–390. doi: 10.1038/236385a0. [DOI] [PubMed] [Google Scholar]
  5. Bowery N. G., Hill D. R., Hudson A. L. Characteristics of GABAB receptor binding sites on rat whole brain synaptic membranes. Br J Pharmacol. 1983 Jan;78(1):191–206. doi: 10.1111/j.1476-5381.1983.tb09380.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Braestrup C., Squires R. F. Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding. Proc Natl Acad Sci U S A. 1977 Sep;74(9):3805–3809. doi: 10.1073/pnas.74.9.3805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brown E. A., Griffiths R., Harvey C. A., Owen D. A. Pharmacological studies with SK&F 93944 (temelastine), a novel histamine H1-receptor antagonist with negligible ability to penetrate the central nervous system. Br J Pharmacol. 1986 Mar;87(3):569–578. doi: 10.1111/j.1476-5381.1986.tb10199.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cheung Y. D., Barnett D. B., Nahorski S. R. [3H]Rauwolscine and [3H]yohimbine binding to rat cerebral and human platelet membranes: possible heterogeneity of alpha 2-adrenoceptors. Eur J Pharmacol. 1982 Oct 15;84(1-2):79–85. doi: 10.1016/0014-2999(82)90159-5. [DOI] [PubMed] [Google Scholar]
  9. Dam Trung Tuong M., Garbarg M., Schwartz J. C. Pharmacological specificity of brain histamine H2-receptors differs in intact cells and cell-free preparations. Nature. 1980 Oct 9;287(5782):548–551. doi: 10.1038/287548a0. [DOI] [PubMed] [Google Scholar]
  10. Daum P. R., Downes C. P., Young J. M. Histamine-induced inositol phospholipid breakdown mirrors H1-receptor density in brain. Eur J Pharmacol. 1983 Mar 4;87(4):497–498. doi: 10.1016/0014-2999(83)90092-4. [DOI] [PubMed] [Google Scholar]
  11. DeLean A., Munson P. J., Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol. 1978 Aug;235(2):E97–102. doi: 10.1152/ajpendo.1978.235.2.E97. [DOI] [PubMed] [Google Scholar]
  12. Dent C., Nilam F., Smith I. R. Sidechain-modified histamine analogues as substrates for histamine N-methyltransferase. Biochem Pharmacol. 1982 Jul 1;31(13):2297–2300. doi: 10.1016/0006-2952(82)90118-6. [DOI] [PubMed] [Google Scholar]
  13. Dismukes K., Snyder S. H. Histamine turnover in rat brain. Brain Res. 1974 Oct 4;78(3):467–481. doi: 10.1016/0006-8993(74)90929-9. [DOI] [PubMed] [Google Scholar]
  14. Edvinsson L., Cervós-Navarro J., Larsson L. I., Owman C., Rönnberg A. L. Regional distribution of mast cells containing histamine, dopamine, or 5-hydroxytryptamine in the mammalian brain. Neurology. 1977 Sep;27(9):878–883. doi: 10.1212/wnl.27.9.878. [DOI] [PubMed] [Google Scholar]
  15. Edvinsson L., Gross P. M., Mohamed A. Characterization of histamine receptors in cat cerebral arteries in vitro and in situ. J Pharmacol Exp Ther. 1983 Apr;225(1):168–175. [PubMed] [Google Scholar]
  16. Gajtkowski G. A., Norris D. B., Rising T. J., Wood T. P. Specific binding of 3H-tiotidine to histamine H2 receptors in guinea pig cerebral cortex. Nature. 1983 Jul 7;304(5921):65–67. doi: 10.1038/304065a0. [DOI] [PubMed] [Google Scholar]
  17. Garbarg M., Barbin G., Rodergas E., Schwartz J. C. Inhibition of histamine synthesis in brain by alpha-fluoromethylhistidine, a new irreversible inhibitor: in vitro and in vivo studies. J Neurochem. 1980 Nov;35(5):1045–1052. doi: 10.1111/j.1471-4159.1980.tb07858.x. [DOI] [PubMed] [Google Scholar]
  18. Goldschmidt R. C., Hough L. B., Glick S. D., Padawer J. Mast cells in rat thalamus: nuclear localization, sex difference and left-right asymmetry. Brain Res. 1984 Dec 10;323(2):209–217. doi: 10.1016/0006-8993(84)90291-9. [DOI] [PubMed] [Google Scholar]
  19. Green J. P., Johnson C. L., Weinstein H., Maayani S. Antagonism of histamine-activated adenylate cyclase in brain by D-lysergic acid diethylamide. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5697–5701. doi: 10.1073/pnas.74.12.5697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Green J. P., Maayani S. Tricyclic antidepressant drugs block histamine H2 receptor in brain. Nature. 1977 Sep 8;269(5624):163–165. doi: 10.1038/269163a0. [DOI] [PubMed] [Google Scholar]
  21. Gross P. M. Cerebral histamine: indications for neuronal and vascular regulation. J Cereb Blood Flow Metab. 1982;2(1):3–23. doi: 10.1038/jcbfm.1982.2. [DOI] [PubMed] [Google Scholar]
  22. Haas H. L., Konnerth A. Histamine and noradrenaline decrease calcium-activated potassium conductance in hippocampal pyramidal cells. 1983 Mar 31-Apr 6Nature. 302(5907):432–434. doi: 10.1038/302432a0. [DOI] [PubMed] [Google Scholar]
  23. Head R. J., Hjelle J. T., Jarrott B., Berkowitz B., Cardinale G., Spector S. Isolated brain microvessels: preparation, morphology, histamine and catecholamine contents. Blood Vessels. 1980;17(4):173–186. doi: 10.1159/000158247. [DOI] [PubMed] [Google Scholar]
  24. Hegstrand L. R., Kanof P. D., Greengard P. Histamine-sensitive adenylate cyclase in mammalian brain. Nature. 1976 Mar 11;260(5547):163–165. doi: 10.1038/260163a0. [DOI] [PubMed] [Google Scholar]
  25. Hill S. J., Emson P. C., Young J. M. The binding of [3H]mepyramine to histamine H1 receptors in guinea-pig brain. J Neurochem. 1978 Oct;31(4):997–1004. doi: 10.1111/j.1471-4159.1978.tb00139.x. [DOI] [PubMed] [Google Scholar]
  26. Hough L. B., Khandelwal J. K., Goldschmidt R. C., Diomande M., Glick S. D. Normal levels of histamine and tele-methylhistamine in mast cell-deficient mouse brain. Brain Res. 1984 Jan 30;292(1):133–138. doi: 10.1016/0006-8993(84)90897-7. [DOI] [PubMed] [Google Scholar]
  27. Hough L. B., Khandelwal J. K., Green J. P. Histamine turnover in regions of rat brain. Brain Res. 1984 Jan 16;291(1):103–109. doi: 10.1016/0006-8993(84)90655-3. [DOI] [PubMed] [Google Scholar]
  28. Johnson C. L., Mizoguchi H. The interaction of histamine and guanylnucleotides with cardiac adenylate cyclase and its relationship to cardiac contractility. J Pharmacol Exp Ther. 1977 Jan;200(1):174–186. [PubMed] [Google Scholar]
  29. Kanof P. D., Greengard P. Brain histamine receptors as targets for antidepressant drugs. Nature. 1978 Mar 23;272(5651):329–333. doi: 10.1038/272329a0. [DOI] [PubMed] [Google Scholar]
  30. Kanof P. D., Greengard P. Pharmacological properties of histamine-sensitive adenylate cyclase from mammalian brain. J Pharmacol Exp Ther. 1979 Apr;209(1):87–96. [PubMed] [Google Scholar]
  31. Karnushina I. L., Palacios J. M., Barbin G., Dux E., Joó F., Schwartz J. C. Studies on a capillary-rich fraction isolated from brain: histaminic components and characterization of the histamine receptors linked to adenylate cyclase. J Neurochem. 1980 May;34(5):1201–1208. doi: 10.1111/j.1471-4159.1980.tb09960.x. [DOI] [PubMed] [Google Scholar]
  32. Kebabian J. W., Calne D. B. Multiple receptors for dopamine. Nature. 1979 Jan 11;277(5692):93–96. doi: 10.1038/277093a0. [DOI] [PubMed] [Google Scholar]
  33. Maayani S., Hough L. B., Weinstein H., Green J. P. Response of the histamine h2-receptor in brain to antidepressant drugs. Adv Biochem Psychopharmacol. 1982;31:133–147. [PubMed] [Google Scholar]
  34. Maeyama K., Watanabe T., Yamatodani A., Taguchi Y., Kambe H., Wada H. Effect of alpha-fluoromethylhistidine on the histamine content of the brain of W/Wv mice devoid of mast cells: turnover of brain histamine. J Neurochem. 1983 Jul;41(1):128–134. doi: 10.1111/j.1471-4159.1983.tb11823.x. [DOI] [PubMed] [Google Scholar]
  35. Martin L. L., Sanders-Bush E. Comparison of the pharmacological characteristics of 5 HT1 and 5 HT2 binding sites with those of serotonin autoreceptors which modulate serotonin release. Naunyn Schmiedebergs Arch Pharmacol. 1982 Dec;321(3):165–170. doi: 10.1007/BF00505480. [DOI] [PubMed] [Google Scholar]
  36. Nishibori M., Oishi R., Saeki K. Histamine turnover in the brain of different mammalian species: implications for neuronal histamine half-life. J Neurochem. 1984 Dec;43(6):1544–1549. doi: 10.1111/j.1471-4159.1984.tb06076.x. [DOI] [PubMed] [Google Scholar]
  37. Norris D. B., Gajtkowski G. A., Rising T. J. Histamine H2-binding studies in the guinea-pig brain. Agents Actions. 1984 Apr;14(3-4):543–545. doi: 10.1007/BF01973867. [DOI] [PubMed] [Google Scholar]
  38. Olianas M., Oliver A. P., Neff N. H. Correlation between histamine-induced neuronal excitability and activation of adenylate cyclase in the guinea pig hippocampus. Neuropharmacology. 1984 Sep;23(9):1071–1074. doi: 10.1016/0028-3908(84)90131-x. [DOI] [PubMed] [Google Scholar]
  39. Palacios J. M., Garbarg M., Barbin G., Schwartz J. C. Pharmacological characterization of histamine receptors mediating the stimulation of cyclic AMP accumulation in slices from guinea-pig hippocampus. Mol Pharmacol. 1978 Nov;14(6):971–982. [PubMed] [Google Scholar]
  40. Peroutka S. J., Snyder S. H. Regulation of serotonin2 (5-HT2) receptors labeled with [3H]spiroperidol by chronic treatment with the antidepressant amitriptyline. J Pharmacol Exp Ther. 1980 Dec;215(3):582–587. [PubMed] [Google Scholar]
  41. Pollard H., Bischoff S., Schwartz J. C. Turnover of histamine in rat brain and its decrease under barbiturate anesthesia. J Pharmacol Exp Ther. 1974 Jul;190(1):88–99. [PubMed] [Google Scholar]
  42. Quach T. T., Duchemin A. M., Rose C., Schwartz J. C. 3H-Glycogen hydrolysis elicited by histamine in mouse brain slices: selective involvement of H1 receptors. Mol Pharmacol. 1980 May;17(3):301–308. [PubMed] [Google Scholar]
  43. Quik M., Iversen L. L., Larder A., Mackay A. V. Use of ADTN to define specific 3H-spirerone binding to receptors in brain. Nature. 1978 Aug 3;274(5670):513–514. doi: 10.1038/274513c0. [DOI] [PubMed] [Google Scholar]
  44. Salomon Y., Londos C., Rodbell M. A highly sensitive adenylate cyclase assay. Anal Biochem. 1974 Apr;58(2):541–548. doi: 10.1016/0003-2697(74)90222-x. [DOI] [PubMed] [Google Scholar]
  45. Schwartz J. C., Pollard H., Quach T. T. Histamine as a neurotransmitter in mammalian brain: neurochemical evidence. J Neurochem. 1980 Jul;35(1):26–33. doi: 10.1111/j.1471-4159.1980.tb12485.x. [DOI] [PubMed] [Google Scholar]
  46. Snyder S. H., Chang K. J., Kuhar M. J., Yamamura H. I. Biochemical indentification of the mammalian muscarinic cholinergic receptor. Fed Proc. 1975 Sep;34(10):1915–1921. [PubMed] [Google Scholar]
  47. Tran V. T., Chang R. S., Snyder S. H. Histamine H1 receptors identified in mammalian brain membranes with [3H]mepyramine. Proc Natl Acad Sci U S A. 1978 Dec;75(12):6290–6294. doi: 10.1073/pnas.75.12.6290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Wahl M., Kuschinsky W. The dilating effect of histamine on pial arteries of cats and its mediation by H2 receptors. Circ Res. 1979 Feb;44(2):161–165. doi: 10.1161/01.res.44.2.161. [DOI] [PubMed] [Google Scholar]
  49. Watanabe T., Taguchi Y., Shiosaka S., Tanaka J., Kubota H., Terano Y., Tohyama M., Wada H. Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res. 1984 Mar 12;295(1):13–25. doi: 10.1016/0006-8993(84)90811-4. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES